Management of Symptomatic Hyponatremia
For severely symptomatic hyponatremia (seizures, altered mental status, coma), immediately administer 3% hypertonic saline as a 100-150 mL intravenous bolus to increase serum sodium by 5-6 mmol/L within the first 1-6 hours until severe symptoms resolve, but do not exceed 8-10 mmol/L total correction in the first 24 hours. 1, 2, 3
Severity-Based Treatment Algorithm
Severe Symptoms (Medical Emergency)
Severe symptoms include mental status changes, seizures, coma, or cardiorespiratory distress—these indicate cerebral edema requiring immediate intervention.
Immediate Management:
- Transfer to ICU with continuous monitoring 1
- Administer 3% hypertonic saline: 100-150 mL IV bolus 1, 4, 3
- Target: Increase sodium by 5-6 mmol/L over first 1-6 hours 1, 2
- Check serum sodium every 2 hours 1
- Critical safety limit: Do not exceed 8 mmol/L correction in first 24 hours 1, 2
- If 6 mmol/L corrected in 6 hours, increase no more than 2 mmol/L in following 18 hours 1
Calculate sodium deficit: Desired increase (mmol/L) × 0.5 × ideal body weight (kg) 1
Once severe symptoms resolve: Transition to mild symptom or asymptomatic protocol 1
Mild to Moderate Symptoms
Symptoms include nausea, vomiting, headache, confusion without seizures or coma.
Management:
- Transfer to intermediate care unit 1
- Check sodium every 4 hours 1
- Fluid restriction to 1 L/day 1, 4
- For SIADH: Fluid restriction remains cornerstone unless severely symptomatic 1
- For cerebral salt wasting: May require hypertonic saline plus fludrocortisone 1
Context-Specific Considerations
Neurosurgical Patients:
- Rapid correction at >1 mmol/L/hour reserved for acute hyponatremia (<48 hours) with severe symptoms 1
- Subarachnoid hemorrhage patients are exception—treat even at sodium 131-135 mmol/L 1
Cirrhosis Patients: The 2021 AASLD guidelines provide specific thresholds 2:
- Mild (126-135 mmol/L): Monitor only, no water restriction
- Moderate (120-125 mmol/L): Water restriction 1,000 mL/day, stop diuretics
- Severe (<120 mmol/L): Severe water restriction plus albumin infusion
- Symptomatic or pre-transplant: Hypertonic saline for short-term use only
- Correction rate: 4-6 mmol/L per 24 hours, not exceeding 8 mmol/L per 24 hours 2
Critical Safety Considerations
Preventing Osmotic Demyelination Syndrome (ODS)
ODS risk is highest in patients with:
- Advanced liver disease
- Chronic alcoholism
- Severe hyponatremia
- Malnutrition
- Metabolic derangements (hypophosphatemia, hypokalemia)
- Prior encephalopathy 2
If overcorrection occurs: Consider relowering sodium with desmopressin or electrolyte-free water 2
Monitoring Requirements
- Severe symptoms: Q2 hour sodium checks, strict intake/output, daily weights 1
- Monitor urine output closely: High diuresis correlates with overcorrection risk 5
- Symptoms from hypovolemia can mimic severe hyponatremia—distinguish carefully 5
Treatment Nuances by Etiology
SIADH (Euvolemic):
- First-line: Fluid restriction 1 L/day 1, 4
- Second-line if restriction fails: Urea or vaptans 4, 3
- Hypertonic saline only for severe symptoms 1
Cerebral Salt Wasting (Hypovolemic):
- Hypertonic saline PLUS fludrocortisone for 7 days 1
- Add normal saline IVF if no response 1
- Volume expansion is key—opposite approach from SIADH 1
Hypervolemic (Heart Failure/Cirrhosis):
- Sodium AND water restriction 6
- Modify or stop diuretics 2, 6
- Consider albumin infusion in cirrhosis 2, 6
- Vaptans for short-term use (≤30 days) 2
Common Pitfalls to Avoid
Treating chronic hyponatremia too rapidly: Most complications occur with chronic (>48 hours) hyponatremia corrected too fast 1
Confusing SIADH with cerebral salt wasting: SIADH requires fluid restriction; CSW requires volume expansion—opposite treatments 1
Ignoring urine output: High diuresis predicts overcorrection risk 5
Using continuous infusion without monitoring: Bolus administration allows better control and reduces overcorrection risk 4, 5
Exceeding correction limits in cirrhosis: These patients have highest ODS risk—strict adherence to 4-6 mmol/L per day is essential 2